Armata Pharmaceuticals (ARMP) Retained Earnings (2016 - 2018)
Armata Pharmaceuticals (ARMP) has disclosed Retained Earnings for 6 consecutive years, with -$402.0 million as the latest value for Q3 2018.
- Quarterly Retained Earnings fell 2.59% to -$402.0 million in Q3 2018 from the year-ago period, while the trailing twelve-month figure was -$402.0 million through Sep 2018, down 2.59% year-over-year, with the annual reading at -$394.2 million for FY2017, 3.37% down from the prior year.
- Retained Earnings hit -$402.0 million in Q3 2018 for Armata Pharmaceuticals, roughly flat from -$400.4 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$360.3 million in Q3 2015 to a low of -$402.0 million in Q3 2018.
- Historically, Retained Earnings has averaged -$379.9 million across 5 years, with a median of -$381.4 million in 2016.
- Biggest five-year swings in Retained Earnings: increased 6.0% in 2014 and later decreased 5.84% in 2017.
- Year by year, Retained Earnings stood at -$362.0 million in 2014, then fell by 0.14% to -$362.5 million in 2015, then fell by 5.2% to -$381.4 million in 2016, then fell by 3.37% to -$394.2 million in 2017, then dropped by 1.98% to -$402.0 million in 2018.
- Business Quant data shows Retained Earnings for ARMP at -$402.0 million in Q3 2018, -$400.4 million in Q2 2018, and -$397.3 million in Q1 2018.